Make your money go further for just 25p per day

AIM IHT

A tale of 2 investment managers

Sustainability

There were positive trading updates from companies covered here, including a couple of relative newcomers to AIM, as well as two investment managers commanding very different valuations. (Free to read)


Cambridge Cognition: major new pharma client

Cambridge Cognition (AIM: COG), which develops and markets digital solutions to assess brain health, has been awarded contracts for two clinical trials by a top 20 pharmaceutical company to assess the pro-cognitive effects of a new drug in schizophrenia. Together the contracts are worth £700,000 over two years.

This is the second pharmaceutical client to award Cambridge Cognition major contracts for cognitive assessments for schizophrenia in…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Cambridge Cognition

Neuroscience company is on the mend

30/01/2024 · Company Insights

This developer of digital solutions to assess brain health has seen its shares tumble on widening losses and…


Cash generators | Contract wins | Competition

14/06/2023 · Company Insights

News covered here includes excellent results from an investment management business, whose model portfolio service continues…


More on Impax Asset Management

Big contract win | Renewed focus | Recovery play

10/01/2024 · Company Insights

Updates from AIM covered here include news of another acquisition for one of AIM’s largest and…


Quality in a challenging market | Elaborate fairy tales

30/11/2023 · Company Insights

News covered here includes delightfully clean results from one well-established company, without an adjustment in sight…


More on Premier Miton Group

Gaining trust | Cool cosmetics

12/01/2024 · Company Insights

A supplier of modestly priced colour cosmetics continues to impress with another terrific update – the…


Great results | Whopping contracts | Capital efficiency

06/12/2023 · Company Insights

A small company covered here has issued excellent results and sits on a very large cash…


More on Quartix Technologies

Big contract win | Renewed focus | Recovery play

10/01/2024 · Company Insights

Updates from AIM covered here include news of another acquisition for one of AIM’s largest and…


Tales of the unexpected | Where is the cash?

12/12/2023 · Company Insights

Our update here includes an assessment of results from one of AIM’s largest companies, which included…


More on Shoe Zone

Winners and losers from the retail world

19/10/2023 · Company Insights

News covered in our free update here includes another impressive trading update from a business operating…


Big dividends | Upgrades | Director buying

14/07/2023 · Company Insights

News covered here includes encouraging results from a small company in the financial services sector which…


More on Tortilla Mexican Grill

A tale of 2 investment managers

11/01/2022 · Company Insights

There were positive trading updates from companies covered here, including a couple of relative newcomers to…


AIM new arrivals October 2021

03/11/2021 · Company Insights

October proved to be a big month for resources listings on AIM, including a tungsten and…


More Company Insights

Resilience in animal healthcare

Utter gobbledygook | Tough to value

When boring is best

Sign-up to our free email updates

SIGN UP